ArticleBlood advances2021
Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.